33.71
-4.68
(-12.19%)
At close: January 10 at 4:00:02 PM EST
32.11
-1.60
(-4.75%)
After hours: January 10 at 7:41:23 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-84,998.00
-78,997.00
-79,389.00
-115,662.00
-74,263.00
Investing Cash Flow
-38,258.00
44,981.00
-26,293.00
3,022.00
32,755.00
Financing Cash Flow
88,194.00
88,328.00
164.00
78,677.00
192,348.00
End Cash Position
35,441.00
135,774.00
81,462.00
186,980.00
220,943.00
Capital Expenditure
-109.00
-19.00
-943.00
-892.00
-2,064.00
Issuance of Capital Stock
--
17,443.00
--
78,584.00
195,542.00
Repayment of Debt
-44.00
-96.00
-61.00
-79.00
-58.00
Free Cash Flow
-85,107.00
-79,016.00
-80,332.00
-116,554.00
-76,327.00
12/31/2020 - 10/16/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CLDI Calidi Biotherapeutics, Inc.
0.9150
-32.22%
RVPH Reviva Pharmaceuticals Holdings, Inc.
1.8800
+0.53%
BIVI BioVie Inc.
2.2100
-6.36%
SGMT Sagimet Biosciences Inc.
5.18
-3.54%
ASMB Assembly Biosciences, Inc.
15.62
-7.79%
VKTX Viking Therapeutics, Inc.
39.31
-3.18%
TIL Instil Bio, Inc.
19.85
-9.77%
CLRB Cellectar Biosciences, Inc.
0.2823
-9.23%
GLPG Galapagos NV
25.65
-8.95%
ARQT Arcutis Biotherapeutics, Inc.
13.81
-9.56%